COM

BIOTECHNOLOGY INNOVATION ORGANIZATION PAC (BIO PAC)

PAC (qualified). Lobbyist or registrant PAC.

PAC (qualified)Lobbyist or registrant PACMixed activity · 40% Democratic / 58% Republican · 1% unclassifiedInferred from activityMonthly filer

Financial snapshot

FEC bulk summary totals through Dec 31, 2024

Total receipts$267.7K

FEC reported disbursements$335.6KReported total may include noncash accounting entries

Individual contributions$235.1K

FEC reported cash on hand$157K

Coverage Not reported to Dec 31, 2024Contribution refunds $4,565Debts owed by committee $0Last report Not reported

Candidate connections

Candidate identity and documented relationships · 2023–2024

Candidate campaign receiving transfers
AGUILAR, PETEDemocraticFEC reported
U.S. House · California · District 33
Election 2024 · Incumbent · Current candidate
Receiving campaign: PETE AGUILAR FOR CONGRESS
Candidate details & sources
FEC candidate ID: H2CA31125 · 2023–2024 reporting cycle
Candidate campaign receiving transfers
BALDERSON, WILLIAM TROY

Registration details

Locally ingested FEC master-file snapshot for 2023–2024

Committee type: PAC (qualified)
Designation: Lobbyist or registrant PAC
Party affiliation: No party affiliation reported
Treasurer: HACKETT, AIKEN
Filing cadence: Monthly filer
Organization type: Trade association
Connected organization: BIOTECHNOLOGY INNOVATION ORGANIZATION
Cycles loaded: 2026, 2024
Registered address: 1201 NEW YORK AVENUE, NW · SUITE 1300 · WASHINGTON, DC, 200053972

Political alignment

Registration, linked-candidate, and disclosed money-flow evidence

Evidence-based classificationMixed activity · 40% Democratic / 58% Republican · 1% unclassifiedMixed activity · 40% Democratic / 58% Republican · 1% unclassifiedInferred from activity

FEC registration: PAC (qualified); no party affiliation reported. Classification basis: Inferred from activity. This describes disclosed financial activity, not an official party registration or ideological score. The figures below separately preserve the filer’s Schedule E support and opposition designations.

No candidate support/oppose spending foundThis cycle has no locally ingested Schedule E rows for this committee. Registration, linked-candidate, committee-transfer, and recipient-reported conduit evidence can still establish the alignment shown above.

$0 supporting · $0 opposing · 0 rowsOfficial FEC outside spending ↗

Source & provenance

Trace this profile back to the public record

Source agencyFederal Election Commission

Local row ingestedSep 4, 2026

Source row hashd493e0d0e9974e58b28155877537431b991128afe6705bc44154599b795eb3d1

View official FEC record

Financial figures are processed FEC totals and may change when amended reports are filed. Registration fields preserve raw master-file values loaded for the 2023–2024 snapshot.

Contributor	Reported context	Date	Election	Amount	FEC record
TAKEDA PHARMACEUTICALS AMERICA INC. POLITICAL ACTION COMMITTEE`C00441733`Supports Mixed activity · 49% Democratic / 50% Republican · 1% unclassifiedInferred from activityLEXINGTON MA 02421	Not reportedM10Linked: C00441733	Sep 28, 2023	Primary (P)	$5,000	Original filing ↗
BLUM, ROBERT`View reported donor profile →`Supports 40% Democratic / 58% Republican · 1% unclassifiedDerived from contributionsSOUTH SAN FRANCISCO CA 94080	PRESIDENT & CEO CYTOKINETICS, INC.M7	Jun 21, 2024	Primary (P)	$5,000	Original filing ↗
AMGEN INC. POLITICAL ACTION COMMITTEE`C00251876`Supports Mixed activity · 36% Democratic / 63% Republican · 1% unclassifiedInferred from activityWASHINGTON DC 20005	Not reportedM6Linked: C00251876	May 31, 2023	Primary (P)	$5,000	Original filing ↗
CROWLEY, JOHN`View reported donor profile →`Supports 40% Democratic / 58% Republican · 1% unclassifiedDerived from contributionsPHILADELPHIA PA 19104	CHAIRMAN OF THE BOARD & CEO AMICUS THERAPEUTICS, INCM6	May 20, 2023	Primary (P)	$5,000	Original filing ↗
MIKHAIL, SHEILA`View reported donor profile →`Supports 40% Democratic / 58% Republican · 1% unclassifiedDerived from contributionsRESEARCH TRIANGLE PARK NC 27709	CEO/CO-FOUNDER ASKBIOM4	Mar 29, 2024	Primary (P)	$5,000	Original filing ↗
ARBUCKLE, STUART`View reported donor profile →`Supports 48% Democratic / 51% Republican · 1% unclassifiedDerived from contributionsBOSTON MA 02210	EVP, CCO & COO VERTEX PHARMACEUTICALS INC.M4	Mar 27, 2023	Primary (P)	$5,000	Original filing ↗
LOVE, TED`View reported donor profile →`Supports 40% Democratic / 58% Republican · 1% unclassifiedDerived from contributionsSOUTH SAN FRANCISCO CA 94080	CHIEF EXECUTIVE OFFICER GLOBAL BLOOD THERAPEUTICSM3	Feb 28, 2024	Primary (P)	$5,000	Original filing ↗
CROWLEY, JOHN`View reported donor profile →`Supports 40% Democratic / 58% Republican · 1% unclassifiedDerived from contributionsPHILADELPHIA PA 19104	CHAIRMAN OF THE BOARD & CEO AMICUS THERAPEUTICS, INCM3	Feb 5, 2024	Primary (P)	$5,000	Original filing ↗
SHERMAN, JEFFREY W.`View reported donor profile →`Supports 40% Democratic / 58% Republican · 1% unclassifiedDerived from contributionsDEERFIELD IL 60015	EXECUTIVE VP, CMO HORIZON THERAPEUTICSM3	Feb 23, 2023	Primary (P)	$5,000	Original filing ↗
MERCK & CO., INC., EMPLOYEES POLITICAL ACTION COMMITTEE (MERCK PAC)`C00097485`Supports Mixed activity · 37% Democratic / 62% Republican · 1% unclassifiedInferred from activityWASHINGTON DC 20004	Not reported30GLinked: C00097485	Oct 31, 2024	Primary (P)	$5,000	Original filing ↗

Recipient	Purpose	Date	Amount	FEC record
CRAPO VICTORY COMMITTEE`C00649574`ALEXANDRIA, VA	24KM12 24KLinked: C00649574	Nov 9, 2023	$5,000	FEC disbursement search ↗
M-PAC`C00365270`SEATTLE, WA	24KM10 24KLinked: C00365270	Sep 26, 2024	$5,000	FEC disbursement search ↗
NEW DEMOCRAT COALITION ACTION FUND`C00409730`WASHINGTON, DC	24KM7 24KLinked: C00409730	Jun 29, 2023	$5,000	FEC disbursement search ↗

BIOTECHNOLOGY INNOVATION ORGANIZATION PAC (BIO PAC)

Financial snapshot

Candidate connections

Registration details

Political alignment

Source & provenance

FEC-reported relationships

Money network

Cash, assets & liabilities

Receipts

Contribution breakdowns

Largest itemized receipts

Disbursements

Largest disbursements

Loans, debts & allocations

Reports & filings